Rennova Health, Inc. (RNVA)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Rennova Health, Inc. (RNVA) trades at $0.00 with AI Score 57/100 (Grade B). Rennova Health, Inc. operates healthcare facilities in the United States. Market cap: $4.31M, Sector: Healthcare.
Price live · AI analysis from Mar 15, 2026Analyst Coverage for RNVA: RNVA does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates RNVA against Healthcare peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
RNVA: 1/4 perspectives are bullish. Dominant signal: Seth Klarman bullish.
How is this calculated? →Rennova Health, Inc. (RNVA) Healthcare & Pipeline Overview
Rennova Health, Inc. provides healthcare services through its hospitals and clinics, primarily operating in Tennessee and Kentucky. With a focus on acute care and rural healthcare access, the company faces challenges in a competitive landscape while striving to maintain patient care standards and navigate the evolving healthcare regulatory environment.
What Is the Investment Thesis for RNVA?
Rennova Health, Inc. presents a challenging investment case given its current financial metrics. The company's negative P/E ratio of -0.42 and a profit margin of -41.4% indicate significant profitability issues. While the gross margin of 59.5% suggests potential in its core operations, the company needs to address its cost structure and revenue generation. Key growth catalysts include expanding services within its existing facilities and potentially acquiring additional healthcare facilities. However, potential risks include regulatory compliance, competition, and the company's ability to achieve sustainable profitability. Investors should closely monitor Rennova Health's financial performance and strategic initiatives to assess its long-term viability.
Based on FMP financials and quantitative analysis
RNVA Key Highlights
- Market capitalization of $4.31M indicates a small-cap company with potential for high volatility.
- Negative P/E ratio of -0.42 reflects current unprofitability.
- Profit margin of -41.4% highlights significant challenges in achieving profitability.
- Gross margin of 59.5% suggests potential in core operations if costs are managed effectively.
- Beta of -0.05 indicates low correlation with the overall market, potentially offering some downside protection.
Who Are RNVA's Competitors?
RNVA is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| IDXG Interpace Biosciences, Inc. | $1.65 | +2.48% | $45.71M | 51 |
| PRE Prenetics Global Limited | $17.25 | +1.88% | $293.23M | 69 |
| EPGNY Epigenomics AG | $2.39 | +0.00% | 68 | |
| STRRP Star Equity Holdings, Inc. | $9.89 | -0.10% | $40.58M | 68 |
| TWST Twist Bioscience Corporation | $100.97 | +1.74% | $6.29B | 65 |
| PRPO Precipio, Inc. | $24.71 | -2.18% | $44.17M | 57 |
| CDNA CareDx, Inc | $29.64 | +1.54% | $1.53B | 57 |
| OLK Olink Holding AB (publ) | $26.08 | +0.31% | $3.24B | 58 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are RNVA's Key Strengths?
- Local presence in rural markets.
- Established healthcare facilities.
- Focus on underserved populations.
- Gross margin of 59.5%.
What Are RNVA's Weaknesses?
- Negative P/E ratio of -0.42.
- Profit margin of -41.4%.
- Limited geographic reach.
- Small market capitalization.
What Could Drive RNVA Stock Higher?
- Efforts to improve operational efficiency and reduce costs.
- Expansion of services within existing healthcare facilities.
- Potential acquisitions of additional healthcare facilities.
- Implementation of telehealth services to expand reach.
- Strategic partnerships with local healthcare providers.
What Are the Key Risks for RNVA?
- Regulatory compliance challenges and changes in healthcare policies.
- Competition from larger healthcare providers and hospital systems.
- Economic downturn affecting patient volumes and revenue.
- Negative P/E ratio and low profit margin indicating financial instability.
- Limited liquidity and potential price volatility due to OTC trading.
What Are the Growth Opportunities for RNVA?
- Expanding Services in Existing Facilities: Rennova Health can grow by expanding the range of medical services offered at its existing hospitals and clinics. This includes adding specialized treatments, diagnostic capabilities, and rehabilitation programs. The market for specialized healthcare services is growing, driven by an aging population and increasing prevalence of chronic diseases. By investing in new technologies and attracting skilled medical professionals, Rennova Health can attract more patients and increase revenue. Timeline: Ongoing.
- Acquiring Additional Healthcare Facilities: Rennova Health can pursue growth through strategic acquisitions of additional hospitals, clinics, or physician practices. This would allow the company to expand its geographic reach and increase its patient base. The market for healthcare acquisitions is active, with opportunities to acquire distressed or underperforming assets. By carefully evaluating potential acquisitions and integrating them effectively, Rennova Health can achieve economies of scale and improve its overall financial performance. Timeline: Ongoing.
- Improving Operational Efficiency: Rennova Health can improve its profitability by focusing on operational efficiency. This includes streamlining administrative processes, reducing costs, and optimizing resource utilization. The market for healthcare efficiency solutions is growing, driven by the need to control costs and improve patient outcomes. By implementing lean management principles and investing in technology, Rennova Health can reduce waste, improve productivity, and enhance its competitive position. Timeline: Ongoing.
- Telehealth Services Expansion: Rennova Health can leverage telehealth to extend its reach and provide convenient access to healthcare services. The telehealth market is experiencing rapid growth, driven by technological advancements and increasing consumer demand. By offering virtual consultations, remote monitoring, and online prescription refills, Rennova Health can attract new patients and improve patient satisfaction. This expansion can be particularly beneficial in rural areas where access to specialists may be limited. Timeline: Ongoing.
- Partnerships with Local Healthcare Providers: Rennova Health can form strategic partnerships with other healthcare providers in its region to expand its network and offer a wider range of services. This includes collaborating with specialists, hospitals, and rehabilitation centers to provide coordinated care to patients. The market for healthcare partnerships is growing, driven by the need to improve patient outcomes and reduce costs. By building strong relationships with local providers, Rennova Health can enhance its reputation and attract more patients. Timeline: Ongoing.
What Opportunities Does RNVA Have?
- Expanding services in existing facilities.
- Acquiring additional healthcare facilities.
- Improving operational efficiency.
- Telehealth services expansion.
What Threats Does RNVA Face?
- Regulatory compliance challenges.
- Competition from larger healthcare providers.
- Economic downturn affecting patient volumes.
- Changes in healthcare reimbursement policies.
What Are RNVA's Competitive Advantages?
- Local presence in rural communities.
- Established healthcare facilities.
- Relationships with local physicians.
- Focus on underserved populations.
What Does RNVA Do?
Rennova Health, Inc. was founded in 2005 and is headquartered in West Palm Beach, Florida. The company operates in the healthcare services sector, primarily focusing on providing medical services through its subsidiaries. As of December 31, 2021, Rennova Health owns and operates one operating hospital in Oneida, Tennessee, an acute care hospital and a physician's practice in Jamestown, Tennessee, and a rural clinic in Williamsburg, Kentucky. These facilities offer a range of medical services to their respective communities. The company's operations are concentrated in providing healthcare access in rural areas, addressing the needs of underserved populations. Rennova Health aims to deliver quality patient care while navigating the complexities of the healthcare industry. The company's business model involves managing and operating healthcare facilities, providing medical services, and generating revenue through patient care and related services. Rennova Health faces competition from other healthcare providers and must adhere to regulatory requirements and industry standards to maintain its operations and market position.
What Products and Services Does RNVA Offer?
- Operates one hospital in Oneida, Tennessee.
- Manages an acute care hospital in Jamestown, Tennessee.
- Oversees a physician's practice in Jamestown, Tennessee.
- Runs a rural clinic in Williamsburg, Kentucky.
- Provides healthcare services to local communities.
- Focuses on acute care and general medical services.
How Does RNVA Make Money?
- Generates revenue through patient care services.
- Operates hospitals and clinics in rural areas.
- Provides acute care and general medical services.
- Manages physician practices.
What Industry Does RNVA Operate In?
Rennova Health operates within the healthcare services industry, which is characterized by increasing demand for medical services, technological advancements, and evolving regulatory landscapes. The industry is highly competitive, with numerous players ranging from large hospital chains to smaller clinics and specialized healthcare providers. Rennova Health's focus on rural healthcare positions it within a niche market, but it also faces challenges related to access to resources and skilled personnel. The company's success depends on its ability to adapt to industry trends, maintain regulatory compliance, and deliver quality patient care in a cost-effective manner.
Who Are RNVA's Key Customers?
- Residents of Oneida, Tennessee.
- Residents of Jamestown, Tennessee.
- Residents of Williamsburg, Kentucky.
- Patients seeking acute care services.
- Individuals requiring general medical care.
Net buyingInsider Activity
The most recent 9 insider filings for Rennova Health, Inc. break down as 1 sales and 8 purchases. On net that is roughly 159.4M shares acquired (about $333K) — insiders putting money in tends to read as conviction.
RNVA Valuation & Market Position
With a $4.31M market cap, Rennova Health, Inc. sits in the micro-cap segment of the market. Relative to its peer group, RNVA's quantitative score of 57/100 is roughly in line with the peer average of 64/100.
ROE 23%Key Financial Metrics
Return on equity for Rennova Health, Inc. stands at 23.5%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -38.2%, showing how much profit it generates from its asset base. Its free cash flow yield is 70.5%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.16 means current liabilities exceed short-term assets, a liquidity point worth watching.
F-Score 4/9Financial Health
Rennova Health, Inc.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile.
Company Profile
Rennova Health, Inc. operates in the Medical - Diagnostics & Research industry within the Healthcare sector. It is headquartered in West Palm Beach, US. The company is led by CEO Seamus Lagan. RNVA has traded publicly since 1995.
RNVA Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in Rennova's future, indicating that those closest to the company expect positive developments.
- Community sentiment has shifted positively, with discussions highlighting potential growth in their healthcare services.
- Rennova's focus on expanding its diagnostic services aligns with increasing demand for healthcare solutions, which is gaining traction among investors.
- Recent partnerships have generated buzz, suggesting a strategic direction that could enhance their market positioning.
Bear Case
- Concerns about Rennova's financial stability continue to circulate, with many in the community questioning its long-term viability.
- Recent negative news coverage has influenced public perception, leading to skepticism about the company's recovery plans.
- Insider selling in the past raised red flags, causing some investors to doubt the commitment of leadership to the company's success.
- Overall market volatility in the healthcare sector has created a cautious atmosphere, making investors wary of potential risks associated with Rennova.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · April 2026
RNVA Latest News
No recent news available for RNVA.
RNVA Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for RNVA.
Price Targets
Wall Street price target analysis for RNVA.
RNVA MoonshotScore
What does this score mean?
The MoonshotScore rates RNVA's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Seamus Lagan
CEO
Seamus Lagan serves as the CEO of Rennova Health, Inc. His background includes experience in managing healthcare operations and driving strategic growth initiatives. He is responsible for overseeing the company's overall performance, developing and implementing business strategies, and ensuring compliance with regulatory requirements. His leadership is focused on improving patient care, enhancing operational efficiency, and creating value for shareholders.
Track Record: Under Seamus Lagan's leadership, Rennova Health has focused on maintaining its healthcare facilities and navigating the challenges of the healthcare industry. Key milestones include efforts to improve operational efficiency and enhance patient care services. He is focused on strategic decisions to improve the company's financial performance and market position.
RNVA OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Rennova Health may not meet the minimum financial standards or disclosure requirements for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial reporting and may not be subject to the same level of regulatory scrutiny as companies listed on major exchanges like the NYSE or NASDAQ. This tier is often associated with higher risk and greater potential for volatility compared to exchange-listed stocks.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure increases information asymmetry.
- Lower trading volume can lead to price volatility.
- Higher risk of fraud or manipulation compared to exchange-listed stocks.
- Potential for delisting or trading suspension.
- Limited regulatory oversight.
- Verify the company's financial statements and SEC filings (if any).
- Research the background and experience of the company's management team.
- Assess the company's business model and competitive landscape.
- Evaluate the company's legal and regulatory compliance.
- Review the company's ownership structure and shareholder base.
- Check for any history of fraud or regulatory violations.
- Consult with a qualified financial advisor.
- Operational healthcare facilities in multiple states.
- Experienced CEO with healthcare management background.
- History of providing healthcare services to local communities.
- Gross margin of 59.5% indicates potential in core operations.
- Focus on underserved populations.
What Investors Ask About Rennova Health, Inc. (RNVA) — Healthcare
What does Rennova Health, Inc. do?
Rennova Health, Inc. operates healthcare facilities, including hospitals and clinics, primarily in Tennessee and Kentucky. The company focuses on providing acute care and general medical services to local communities. Rennova Health aims to address the healthcare needs of underserved populations in rural areas by offering a range of medical services through its facilities. The company's business model involves managing and operating these healthcare facilities, generating revenue through patient care, and navigating the complexities of the healthcare industry.
What are the main risks for RNVA?
Rennova Health faces several key risks, including regulatory compliance challenges, competition from larger healthcare providers, and economic downturns affecting patient volumes. The company's financial instability, as indicated by its negative P/E ratio and low profit margin, also poses a significant risk. Additionally, trading on the OTC market exposes the company to limited liquidity and potential price volatility. Investors should carefully consider these risks and conduct thorough due diligence before investing in RNVA.
What are the key factors to evaluate for RNVA?
Rennova Health, Inc. (RNVA) holds an AI score of 57/100 (moderate). Not financial advice.
How frequently does RNVA data refresh on this page?
RNVA prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven RNVA's recent stock price performance?
Rennova Health, Inc. (RNVA) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Local presence in rural markets. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider RNVA overvalued or undervalued right now?
Valuing Rennova Health, Inc. (RNVA) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying RNVA?
Before investing in Rennova Health, Inc. (RNVA), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding RNVA to a portfolio?
Key strength of Rennova Health, Inc. (RNVA): Local presence in rural markets. Weigh rewards against risks and diversify. Not financial advice.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited financial data available for Rennova Health, Inc.
- OTC market investments carry higher risk.